Subject(s)
Lung/physiology , Mice, Transgenic , Models, Animal , Peptides/genetics , Promoter Regions, Genetic , Proteins/genetics , Pulmonary Surfactants/genetics , Uteroglobin , Animals , Fibroblast Growth Factor 10 , Fibroblast Growth Factors/metabolism , Intercellular Signaling Peptides and Proteins , Mice , Pulmonary Surfactant-Associated Protein C , Transcriptional ActivationABSTRACT
Transgenic mice in which fibroblast growth factor (FGF)-10 was expressed in the lungs of fetal and postnatal mice were generated with a doxycycline-inducible system controlled by surfactant protein (SP) C or Clara cell secretory protein (CCSP) promoter elements. Expression of FGF-10 mRNA in the fetal lung caused adenomatous malformations, perturbed branching morphogenesis, and caused respiratory failure at birth. When expressed after birth, FGF-10 caused multifocal pulmonary tumors. FGF-10-induced tumors were highly differentiated papillary and lepidic pulmonary adenomas. Epithelial cells lining the tumors stained intensely for thyroid transcription factor (TTF)-1 and SP-C but not CCSP, indicating that FGF-10 enhanced differentiation of cells to a peripheral alveolar type II cell phenotype. Withdrawal from doxycycline caused rapid regression of the tumors associated with rapid loss of the differentiation markers TTF-1, SP-B, and proSP-C. FGF-10 disrupted lung morphogenesis and induced multifocal pulmonary tumors in vivo and caused reversible type II cell differentiation of the respiratory epithelium.
Subject(s)
Adenoma/chemically induced , Animals, Newborn/growth & development , Fetus/physiology , Fibroblast Growth Factors/pharmacology , Lung Neoplasms/chemically induced , Lung/embryology , Lung/growth & development , Uteroglobin , Adenoma/ultrastructure , Animals , Doxycycline , Embryonic and Fetal Development/drug effects , Fibroblast Growth Factor 10 , Fibroblast Growth Factors/genetics , Intercellular Signaling Peptides and Proteins , Lung/drug effects , Lung/metabolism , Lung Neoplasms/ultrastructure , Mice , Mice, Transgenic/genetics , Nuclear Proteins/metabolism , Peptides/metabolism , Protein Precursors/metabolism , Proteins/genetics , Proteins/pharmacology , Proteolipids/metabolism , Pulmonary Surfactant-Associated Protein C , Pulmonary Surfactants/metabolism , RNA, Messenger/metabolism , Thyroid Nuclear Factor 1 , Transcription Factors/metabolismABSTRACT
The complex process of lung formation is determined by the action of numerous genes that influence cell commitment, differentiation, and proliferation. This review summarizes current knowledge of various factors involved in lung morphogenesis correlating their temporal and spatial expression with their proposed functions at various times during the developmental process. Rapid progress in understanding the pathways involved in lung morphogenesis will likely provide the framework with which to elucidate the mechanisms contributing to lung malformations and the pathogenesis of genetic and acquired lung diseases.
Subject(s)
Embryonic and Fetal Development/genetics , Lung/embryology , Morphogenesis , Animals , HumansABSTRACT
As in the development of many human cancers, in a transgenic mouse model of beta-cell carcinogenesis (Rip1Tag2), expression of neural cell adhesion molecule (NCAM) changes from the 120-kDa isoform in normal tissue to the 140/180-kDa isoforms in tumors. NCAM-deficient RiplTag2 mice, generated by crossing Rip1Tag2 mice with NCAM knockout mice, develop metastases, a tumor stage that is not seen in normal Rip1Tag2 mice. In contrast, overexpression of NCAM 120 in NCAM-deficient Rip1Tag2 mice prevents tumor metastasis. The results indicate that the loss of NCAM-mediated cell adhesion is one rate-limiting step in the actual metastatic dissemination of beta tumor cells.
Subject(s)
Gene Expression Regulation, Neoplastic , Insulinoma/physiopathology , Neural Cell Adhesion Molecules/genetics , Pancreatic Neoplasms/physiopathology , Animals , Disease Progression , Gene Dosage , Humans , Insulinoma/genetics , Insulinoma/metabolism , Islets of Langerhans/cytology , Islets of Langerhans/metabolism , Mesoderm , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Neoplasm Metastasis , Neural Cell Adhesion Molecules/physiology , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/metabolism , Protein Isoforms , Tumor Cells, CulturedABSTRACT
Classical cell dissociation/reaggregation experiments with embryonic tissue and cultured cells have established that cellular cohesiveness, mediated by cell adhesion molecules, is important in determining the organization of cells within tissue and organs. We have employed N-CAM-deficient mice to determine whether N-CAM plays a functional role in the proper segregation of cells during the development of islets of Langerhans. In N-CAM-deficient mice the normal localization of glucagon-producing alpha cells in the periphery of pancreatic islets is lost, resulting in a more randomized cell distribution. In contrast to the expected reduction of cell-cell adhesion in N-CAM-deficient mice, a significant increase in the clustering of cadherins, F-actin, and cell-cell junctions is observed suggesting enhanced cadherin-mediated adhesion in the absence of proper N-CAM function. These data together with the polarized distribution of islet cell nuclei and Na+/K+-ATPase indicate that islet cell polarity is also affected. Finally, degranulation of beta cells suggests that N-CAM is required for normal turnover of insulin-containing secretory granules. Taken together, our results confirm in vivo the hypothesis that a cell adhesion molecule, in this case N-CAM, is required for cell type segregation during organogenesis. Possible mechanisms underlying this phenomenon may include changes in cadherin-mediated adhesion and cell polarity.
Subject(s)
Islets of Langerhans/cytology , Neural Cell Adhesion Molecules/physiology , Animals , Cadherins/biosynthesis , Cadherins/genetics , Epithelial Cells/cytology , Gene Expression , L Cells , Mice , Mice, Inbred C57BL , Mice, Knockout , Neural Cell Adhesion Molecules/geneticsABSTRACT
Development of malignant tumours is in part characterized by the ability of a tumour cell to overcome cell-cell adhesion and to invade surrounding tissue. E-cadherin is the main adhesion molecule of epithelia, and it has been implicated in carcinogenesis because it is frequently lost in human epithelial cancers. Re-establishing the functional cadherin complex in tumour cell lines results in a reversion from an invasive to a benign epithelial phenotype. However, it remained unresolved whether the loss of E-cadherin-mediated cell adhesion was a cause or a consequence of tumour progression in vivo. Here we report that the loss of E-cadherin expression coincides with the transition from well differentiated adenoma to invasive carcinoma in a transgenic mouse model of pancreatic beta-cell carcinogenesis (Rip1Tag2). Intercrossing Rip1Tag2 mice with transgenic mice that maintain E-cadherin expression in beta-tumour cells results in arrest of tumour development at the adenoma stage, whereas expression of a dominant-negative form of E-cadherin induces early invasion and metastasis. The results demonstrate that loss of E-cadherin-mediated cell adhesion is one rate-limiting step in the progression from adenoma to carcinoma.
